Executive IRB Chair
Executive leadership across all IRB committee operations, reviewer governance, meeting management, and regulatory review within a PE-backed commercial central IRB supporting FDA-regulated and Common Rule research across drug, biologic, and medical device programs. Functional Owner of Board Service Delivery - accountable for board governance, reviewer infrastructure, KPI development, and Management System participation. Experienced in FDA inspection readiness activities resulting in inspection closure without findings, and represents the organization in FDA inspections, AAHRPP site visits, and sponsor audits. Performs full-board, expedited, exempt, and chair reviews; serves as liaison between the committee and sponsors on IRB requirements and determinations.